Eeva Ruotsalainen

1.1k total citations
36 papers, 762 citations indexed

About

Eeva Ruotsalainen is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eeva Ruotsalainen has authored 36 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 17 papers in Epidemiology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eeva Ruotsalainen's work include Antimicrobial Resistance in Staphylococcus (21 papers), Streptococcal Infections and Treatments (15 papers) and Bacterial Identification and Susceptibility Testing (11 papers). Eeva Ruotsalainen is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (21 papers), Streptococcal Infections and Treatments (15 papers) and Bacterial Identification and Susceptibility Testing (11 papers). Eeva Ruotsalainen collaborates with scholars based in Finland, United States and Sweden. Eeva Ruotsalainen's co-authors include Asko Järvinen, Erik Forsblom, Ville Valtonen, Jukka Ollgren, Outi Lyytikäinen, Jaakko Karvonen, Petri Ruutu, Pentti Kuusela, Christian W. Thorball and Seppo Sarna and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Infection and Immunity.

In The Last Decade

Eeva Ruotsalainen

33 papers receiving 729 citations

Peers

Countries citing papers authored by Eeva Ruotsalainen

Since Specialization

Citations

This map shows the geographic impact of Eeva Ruotsalainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eeva Ruotsalainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eeva Ruotsalainen more than expected).

Fields of papers citing papers by Eeva Ruotsalainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eeva Ruotsalainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eeva Ruotsalainen. The network helps show where Eeva Ruotsalainen may publish in the future.

Co-authorship network of co-authors of Eeva Ruotsalainen

This figure shows the co-authorship network connecting the top 25 collaborators of Eeva Ruotsalainen. A scholar is included among the top collaborators of Eeva Ruotsalainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eeva Ruotsalainen. Eeva Ruotsalainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Corticosteroids, rifampicin and LMWH impact plasma aMMP-8 and TIMP-1 and aMMP-8/TIMP-1 molar ratio in methicillin-sensitive Staphylococcus aureus bacteremia 2025 ·International Journal of Infectious Diseases ·Erik Forsblom, (unknown), (unknown), Eeva Ruotsalainen, Taina Tervahartiala, Timo Sorsa	0
2	Molecular characteristics of Cryptosporidium spp. in human cases in five Finnish hospital districts during 2021: first findings of Cryptosporidium mortiferum (Cryptosporidium chipmunk genotype I) in Finland 2024 ·International Journal for Parasitology ·(unknown), Ruska Rimhanen‐Finne, Jenni Antikainen, Eeva Ruotsalainen, Anni Vainio	4
3	Tuberculosis contact investigation results among paediatric contacts in low-incidence settings in Finland 2021 ·European Journal of Pediatrics ·(unknown), (unknown), Eeva Ruotsalainen, Eeva Salo	8
4	Formal infectious diseases specialist consultation improves long-term outcome of methicillin-sensitive Staphylococcus aureus bacteremia 2019 ·Open Forum Infectious Diseases ·Erik Forsblom, Heikki Frilander, Eeva Ruotsalainen, (unknown)	6
5	Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses 2019 ·Vaccine ·Anu Haveri, Niina Ikonen, Anu Kantele, Veli‐Jukka Anttila, Eeva Ruotsalainen, Carita Savolainen‐Kopra, Ilkka Julkunen	2
6	Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study 2018 ·Infection ·Erik Forsblom, (unknown), Eeva Ruotsalainen, Asko Järvinen	7
7	Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·Erik Forsblom, Eeva Ruotsalainen, Asko Järvinen	6
8	Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia 2016 ·PLoS ONE ·(unknown), Eeva Ruotsalainen, Esa Rintala, Asko Järvinen	18
9	Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia? 2016 ·European Journal of Clinical Microbiology & Infectious Diseases ·Erik Forsblom, (unknown), Eeva Ruotsalainen, Asko Järvinen	5
10	Improved Outcome with Early Rifampicin Combination Treatment in Methicillin-Sensitive Staphylococcus aureus Bacteraemia with a Deep Infection Focus – A Retrospective Cohort Study 2015 ·PLoS ONE ·Erik Forsblom, Eeva Ruotsalainen, Asko Järvinen	20
11	Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine 2015 ·Työväentutkimus Vuosikirja ·(unknown), Niina Ikonen, Ilkka Julkunen, Anu Kantele, Veli‐Jukka Anttila, Eeva Ruotsalainen, Hanna Nohynek, Outi Lyytikäinen, Carita Savolainen‐Kopra	2
12	High Cell-Free DNA Predicts Fatal Outcome among Staphylococcus aureus Bacteraemia Patients with Intensive Care Unit Treatment 2014 ·PLoS ONE ·Erik Forsblom, Janne Aittoniemi, Eeva Ruotsalainen, (unknown), Reetta Huttunen, Juulia Jylhävä, Mikko Hurme, Asko Järvinen	35
13	Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in the Management of Staphylococcus aureus Bacteremia 2012 ·Clinical Infectious Diseases ·Erik Forsblom, Eeva Ruotsalainen, Jukka Ollgren, Asko Järvinen	101
14	Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia 2011 ·Journal of Hospital Infection ·Erik Forsblom, Eeva Ruotsalainen, (unknown), Jukka Ollgren, O. Lyytikäinen, Asko Järvinen	30
15	Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Eeva Ruotsalainen, Christian W. Thorball, Asko Järvinen	50
16	Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: Host factors, microbiological and serological characteristics 2008 ·Journal of Infection ·Eeva Ruotsalainen, (unknown), Pentti Kuusela, Jaana Vuopio‐Varkila, Anni Virolainen-Julkunen, Seppo Sarna, Ville Valtonen, Asko Järvinen	20
17	Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients 2006 ·BMC Infectious Diseases ·Eeva Ruotsalainen, Kari Sammalkorpi, Janne Laine, Kaisa Huotari, Seppo Sarna, Ville Valtonen, Asko Järvinen	65
18	Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients 2005 ·Journal of Internal Medicine ·Eeva Ruotsalainen, Asko Järvinen, Irma Koivula, Heikki Kauma, Esa Rintala, Jukka Lumio, Pirkko Kotilainen, Martti Vaara, J Nikoskelainen, Ville Valtonen, (unknown)	50
19	Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995–2001 2005 ·European Journal of Clinical Microbiology & Infectious Diseases ·Outi Lyytikäinen, Eeva Ruotsalainen, Asko Järvinen, Ville Valtonen, Petri Ruutu	84
20	Genome diversification in Staphylococcus aureus 2003 ·Infection and Immunity ·(unknown), Sean D. Reid, Eeva Ruotsalainen, Timothy J. Tripp, (unknown), Robert L. Cole, Pentti Kuusela, Patrick M. Schlievert, Asko Järvinen, James M. Musser	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact